TGA Approval

MAVIRET glecaprevir/pibrentasvir 100 mg/40 mg film-coated tablet blister pack (284948)

ARTG ID

284948

ARTG Name

MAVIRET glecaprevir/pibrentasvir 100 mg/40 mg film-coated tablet blister pack

Sponsor

AbbVie Pty Ltd

ARTG Date

January 2, 2018

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

ABBVIE PTY LTD

https://medical-cdn.nocode.com/drug_tga/e0186bd6e96d38804e509f377c5fb411.pdf

https://medical-cdn.nocode.com/drug_tga/9a040e456036049ca312b1c60c01f043.pdf

Ingredient Name

glecaprevir

Ingredient Name

pibrentasvir

Empowering clinical research with data-driven insights and AI-powered tools.

MAVIRET glecaprevir/pibrentasvir 100 mg/40 mg film-coated tablet blister pack (284948) - TGA 批准文号 | MedPath